Navigation Links
Mattel Children's Hospital UCLA launches program in nanopediatrics
Date:10/17/2008

Mattel Children's Hospital UCLA today announced the launch of the Mattel UCLA NanoPediatrics Program, which will explore the future of personalized medicine for children, including the opportunities and risks involved. The program is one of the world's first dedicated solely to nanomedicine and pediatric patients.

"Why develop a nanopediatrics program? Because children are not small adults," said Dr. Edward McCabe, physician-in-chief of Mattel Children's Hospital and founding director of the new program. "We know that drugs affect children they metabolize, excrete and may even utilize, developmentally, specific receptors differently than adults.

"Unless children are included as a research priority for the application of nanotechnology, then we will simply be applying approaches developed for adults. This flawed strategy will place children at risk, as opposed to a program in which children will be the focus from the outset."

Nanotechnology involves manipulating atoms and molecules to create tiny devices, smaller than one-thousandth the diameter of a human hair (a nanometer is one-billionth of a meter). It is anticipated that nanomedicine, fueled by nanotechnology, will enable more personalized medical care that will be both predictive and preventive.

While considerable attention has been paid to nanomedicine, UCLA's nanopediatrics program, initially organized in May 2008, may be the first initiative to examine the promises and risks of nanodiagnostics and nanotherapeutics for children in a formal and organized manner.

Created thanks to a generous $1.8 million gift from the Mattel Children's Foundation, the program will support a nanopediatrics research core and pilot funding for projects that will potentially enable investigators to obtain grants from the National Institutes of Health.

"The Mattel Children's Foundation is excited to support this groundbreaking program in nanopediatrics, which ca
'/>"/>

Contact: Amy Albin
aalbin@mednet.ucla.edu
310-794-8672
University of California - Los Angeles
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
2. George Washington University Hospital Purchases Orthocrats TraumaCad(TM) for Orthopedic Preoperative Planning
3. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
4. Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
5. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
6. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
7. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
8. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
9. States First Single Incision Robotic Kidney Removal Performed at Henry Ford Hospital
10. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
11. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., LONDON, November 30 ApaTec... named Europe,s fastest growing,Biotech/Pharmaceut...eloitte,2009 Technology Fast 500 for EMEA (Europe,...anking is based on a companies, five-year revenue ...,318% over this period. This,achievement places Ap...
(Date:11/28/2009)... The Vanuatu National Advisory Committee o...al Communication (SNC) Project in collaboration wi...tems Ltd. of New Zealand have generated preliminar...ill form the background for the country’s SN...tion on Climate Change (UNFCCC). , ...
(Date:11/27/2009)... A mechanised blue dye test alternative ...quality assurance one step closer for pharma-compa...esting machine developed by Sepha for use with ... several local and global pharma-companies such as...y assurance and productivity improvements on the p...
(Date:11/25/2009)... BOSTON, Nov. 25 Biotech firm Repl...omic data from the 1918 pandemic through the predi...pandemic, today issued its latest biochemical anal...hality of the H1N1 ("Swine Flu") virus has dropped...s current outbreak in the spring of 2009 to restin...
Breaking Biology Technology:ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5
...n Systems, a Madison-based manufacturer of scient...orldwide as the result of licensing and supply agr...y consultancy service headquartered in Oxford, Eng...the British firm will obtain DNA microarrays , wh...el, from NimbleGen for use in its service business...
...l J. Dunn , who has served as executive vice presi... for the past 12 years, has announced that he wil... named. , ,Dunn, 70, will become a distinguished ...edicine once a replacement is found. , , T. Micha...ge, said the institution will begin a national sea...
... District Court for the Western District of Wiscon...bbott Laboratories , preventing the pharmaceutical...components that infringe on a genotyping patent he...based in Gent, Belgium. , ,The injunction comes af...gainst Abbott. In September of 2006, a Wisconsin j...
Other Biology Technology:
(Date:11/26/2009)...t in eight European countries has shown that closi...andemic could have a significant role in reducing ...pen access journal BMC Infectious Diseases compa... weekends/holidays, finding that they were reduced...t and Antwerp University, Belgium, led a team of E...
(Date:11/25/2009)...entists at the California Institute of Technology ...motion-like behavior in the fruit fly, Drosophila...elevant to the relationship between the neurotrans...y disorder (ADHD), are described in the December i... brain contains only about 20,000 neurons and has ...
(Date:11/25/2009)..., Head of the Cell Death Research Laboratory in th... been awarded the prestigious Johnson & Johnson Fo... cause of brain cell damage in Parkinson,s disease...sts in support of innovation and excellence in sci...red earlier this month at an event at the Hyatt Re...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 1U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 2U S Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non Minorities and Business Meeting 47848 3Synthetech Announces Fiscal 2009 Results 47845 1Synthetech Announces Fiscal 2009 Results 47845 2Synthetech Announces Fiscal 2009 Results 47845 3Synthetech Announces Fiscal 2009 Results 47845 4Synthetech Announces Fiscal 2009 Results 47845 5Synthetech Announces Fiscal 2009 Results 47845 6Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference 12455 1Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference 12455 2
...y University of Virginia researchers demonstrates ...c field of moderate strength can result in signifi...y after an inflammatory injury. , Thomas Skalak, ... Cassandra Morris, a former Ph.D. student in biome...s in the November 2007 edition of the American Jou...
...al study investigating the carbon sink capacity of...he duration of the net carbon uptake period (CUP) ...eratures. , Net carbon uptake of northern ecosyst...according to findings recently published January 3...errestrial ecosystems is particularly sensitive to...
... Scientists at Thomas Jefferson University Hospita...d approval for a first-of-its kind study on the ef...ma patients. Researchers from the Jefferson-Myrna ...ncer Center in conjunction with the National Insti...itamin C can slow the progression of the deadly di...
Other Biology News:UVa biomedical engineering study shows magnetic field can reduce swelling 2UVa biomedical engineering study shows magnetic field can reduce swelling 3Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients 2
CORNING IVF CULTURE DISH, 60 X 15MM, PS, STERILE from Sigma-Aldrich
DAPI from KPL
...f glass plates, bar clamp, and a built-in epoxy-co...hese units are:, safety interlock lids , detachabl...wer reservoirs have drains with tubing adapters fo...eling base with bubble level,Each unit comes compl...
...P450 (CYP450) metabolite postulated to play an aut...In rat cerebral microvessels, 20-HETE is a vasocon...tory vasoconstriction. 20-HETE is excreted mainly ... free 20-HETE (20-40 pg/ml in human urine) is abou...
Biology Products: